ODDB.org: Open Drug Database | Drugs

Spirig HealthCare AG - Co-Irbesartan Spirig HC 300/12.5 mg, Filmtabletten

Swissmedic Registration	62743	Sequence	02
Product name	Co-Irbesartan Spirig HC 300/12.5 mg	Description	Filmtabletten
ATC-Classification	C09DA04	ATC-Description	Irbesartan and Diuretics
Introduction of Sequence	05.03.2013

Composition

irbesartanum 300 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 68.32 mg, amylum pregelificatum, copovidonum K 28, carmellosum natricum conexum corresp. natrium 1.07 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Hydrochlorothiazide	12.5 mg
Irbesartan	300 mg

BAG: Active Agent	Dose
Hydrochlorothiazide	12.5 mg
Irbesartan	300 mg

Inactive agents	Dose	additional_information





	28
		color.
		color.
Hypromellosum		Überzug
Lactose Monohydrate	68.32 mg
Macrogol	8000


Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	28 Tablet(s)	12.55	30.05	B	SL	No
004	98 Tablet(s)	43.33	63.55	B	SL	No

2025	©ywesee GmbH